| 标题 |
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Michael J. Morris; Daniel Castellano; Ken Herrmann; Johann S. de Bono; Neal D. Shore; et al 出版日期:2024-09-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)